.png){kind=icon}
.png){kind=icon}
Return
Asthma in pregnancy: optimising treatment strategies and the emerging role of biologic therapies
.png){kind=icon}
OA
AI
DOI：10.1016/j.anai.2026.02.009.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Asthma is the commonest chronic respiratory disease during pregnancy and is a major contributor to preventable maternal morbidity and adverse foetal outcomes when poorly controlled. Although most asthma therapies are considered safe during pregnancy, asthma control frequently deteriorates, reflecting diagnostic uncertainty, suboptimal monitoring, poor treatment adherence, and clinician hesitancy to escalate therapy.
Keywords:
Asthma
Pregnancy
Treatment strategies
Biologic therapies
Maternal morbidity
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
A
IF:
0
Papers:
195
Citations:
0